Surface-modified loaded human red blood cells for targeting and delivery of drugs

References

• Ahn YS, Harrington WJ, Mylvaganam R. Use of platelets as drug carriers for the treatment of hematologic diseases. Methods Enzymol 1987; 149: 312–25
   PubMedGoogle Scholar
• Allen TM. Ligand-targeted therapeutics in anticancer therapy. Nat Rev Cancer 2002; 2: 750–63
   PubMed Web of Science ®Google Scholar
• Bäumler H, Radtke H, Haas T, Latza R, Kiesewetter H. Influence of 30gy gamma irradiation on the quality of red blood concentrates in several storage media. Infusionsther Transfusionsmed 1999; 26: 212–21
   Google Scholar
• Brahler M, Georgieva R, Buske N, Muller A, Muller S, Pinkernelle J, Teichgraber U, Voigt A, Baumler H. Magnetite-loaded carrier erythrocytes as contrast agents for magnetic resonance imaging. Nano Lett 2006; 6: 2505–9
   PubMed Web of Science ®Google Scholar
• Bratosin D, Mazurier J, Tissier JP, Estaquier J, Huart JJ, Ameisen JC, Aminoff D, Montreuil J. Cellular and molecular mechanisms of senescent erythrocyte phagocytosis by macrophages. A review. Biochimie 1998; 80: 173–95
   PubMed Web of Science ®Google Scholar
• Chambers E, Mitragoni S. Prolonged circulation of large polymeric nanoparticles by non-covalent adsorption on erythrocytes. J Control Release 2004; 100: 111–19
   PubMed Web of Science ®Google Scholar
• Chanana M, Jahn S, Georgieva R, Lutz JF, Baumler H, Wang DY. Fabrication of colloidal stable, thermosensitive, and biocompatible magnetite nanoparticles and study of their reversible agglomeration in aqueous milieu. Chemistry of Materials 2009; 21: 1906–14
   Web of Science ®Google Scholar
• Daleke DL. Regulation of transbilayer plasma membrane phospholipid asymmetry. J Lipid Res 2003; 44: 233–42
   PubMed Web of Science ®Google Scholar
• DeLoach JR. Carrier erythrocytes. Med Res Rev 1986; 6: 487–504
   PubMed Web of Science ®Google Scholar
• DeLoach JR, Harris RL, Ihler GM. An erythrocyte encapsulator dialyzer used in preparing large quantities of erythrocyte ghosts and encapsulation of a pesticide in erythrocyte ghosts. Anal Biochem 1980; 102: 220–7
   PubMed Web of Science ®Google Scholar
• Detragli M, Cook FB, Stasiw DM, Cerny LC. Erythrocyte fragility in aging. Biochim Biophys Acta 1974; 345: 213–19
   PubMedGoogle Scholar
• Ding BS, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. Advanced drug delivery systems that target the vascular endothelium. Mol Interv 2006; 6: 98–112
   PubMed Web of Science ®Google Scholar
• Dominici S, Laguardia ME, Serafini G, Chiarantini L, Fortini C, Tripiciano A, Brocca-Cofano E, Scoglio A, Caputo A, Fiorelli V, et al. Red blood cell-mediated delivery of recombinant HIV-1 tat protein in mice induces anti-tat neutralizing antibodies and ctl. Vaccine 2003; 21: 2073–81
   PubMed Web of Science ®Google Scholar
• Duckworth WC, Hamel FG, Bennett R, Ryan MP, Roth RA. Human red blood cell insulin-degrading enzyme and rat skeletal muscle insulin protease share antigenic sites and generate identical products from insulin. J Biol Chem 1990; 265: 2984–7
   PubMedGoogle Scholar
• Franco RS, Weiner M, Wagner K, Martelo OJ. Incorporation of inositol hexaphosphate into red blood cells mediated by dimethyl sulfoxide. Life Sci 1983; 32: 2763–8
   PubMedGoogle Scholar
• Gersh KC, Zaitsev S, Muzykantov V, Cines DB, Weisel JW. The spatial dynamics of fibrin clot dissolution catalyzed by erythrocyte-bound vs. Free fibrinolytics. J Thromb Haemost 2010; 8: 1066–74
   PubMed Web of Science ®Google Scholar
• Ginn FL, Hochstein P, Trump BF. Membrane alterations in hemolysis: Internalization of plasmalemma induced by primaquine. Science 1969; 164: 843–5
   PubMedGoogle Scholar
• Glukhova MA, Domogatsky SP, Kabakov AE, Muzykantov VR, Ornatsky OI, Sakharov DV, Frid MG, Smirnov VN. Red blood cell targeting to smooth muscle cells. FEBS Lett 1986; 198: 155–8
   PubMedGoogle Scholar
• Gorden P, Arakaki R, Collier E, Carpentier JL. Biosynthesis and regulation of the insulin receptor. Yale J Biol Med 1989; 62: 521–31
   PubMedGoogle Scholar
• Hamidi M, Tajerzadeh H. Carrier erythrocytes: An overview. Drug Deliv 2003; 10: 9–20
   PubMed Web of Science ®Google Scholar
• Hamidi M, Zarrin A, Foroozesh M, Mohammadi-Samani S. Applications of carrier erythrocytes in delivery of biopharmaceuticals. J Control Release 2007; 118: 145–60
   PubMed Web of Science ®Google Scholar
• Hinderling PH. Red blood cells: A neglected compartment in pharmacokinetics and pharmacodynamics. Pharmacol Rev 1997; 49: 279–95
   PubMed Web of Science ®Google Scholar
• King GL, Johnson SM. Receptor-mediated transport of insulin across endothelial cells. Science 1985; 227: 1583–6
   PubMed Web of Science ®Google Scholar
• Kinosita K, Jr, Tsong TY. Formation and resealing of pores of controlled sizes in human erythrocyte membrane. Nature 1977; 268: 438–41
   PubMed Web of Science ®Google Scholar
• Kreuter J, Hekmatara T, Dreis S, Vogel T, Gelperina S, Langer K. Covalent attachment of apolipoprotein a-i and apolipoprotein b-100 to albumin nanoparticles enables drug transport into the brain. J Control Release 2007; 118: 54–8
   PubMed Web of Science ®Google Scholar
• Kruse CA, Freehauf CL, Patel KR, Baldeschwieler JD. Mouse erythrocyte carriers osmotically loaded with methotrexate. Biotechnol Appl Biochem 1987; 9: 123–40
   PubMedGoogle Scholar
• Lin YH, Mi FL, Chen CT, Chang WC, Peng SF, Liang HF, Sung HW. Preparation and characterization of nanoparticles shelled with chitosan for oral insulin delivery. Biomacromolecules, 2007;8(1):146–52.
   Google Scholar
• Magnani M. Erythrocyte engineering for drug delivery and targeting. Landes Bioscience/Eurekah.com & Kluwer Academic/Plenum Publishers, New YorkUSA 2003
   Google Scholar
• Magnani M, Chiarantini L, Vittoria E, Mancini U, Rossi L, Fazi A. Red blood cells as an antigen-delivery system. Biotechnol Appl Biochem 1992a; 16: 188–94
   PubMed Web of Science ®Google Scholar
• Magnani M, Mancini U, Bianchi M, Fazi A. Comparison of uricase-bound and uricase-loaded erythrocytes as bioreactors for uric acid degradation. Adv Exp Med Biol 1992b; 326: 189–94
   PubMedGoogle Scholar
• Magnani M, Rossi L, Brandi G, Schiavano GF, Montroni M, Piedimonte G. Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: In vitro and in vivo studies. Proc Natl Acad Sci USA 1992c; 89: 6477–81
   PubMed Web of Science ®Google Scholar
• Magnani M, Rossi L, Fraternale A, Bianchi M, Antonelli A, Crinelli R, Chiarantini L. Erythrocyte-mediated delivery of drugs, peptides and modified oligonucleotides. Gene Ther 2002; 9: 749–51
   PubMed Web of Science ®Google Scholar
• Muzykantov VR. Drug delivery by red blood cells: Vascular carriers designed by mother nature. Expert Opin Drug Deliv 2010; 7: 403–27
   PubMed Web of Science ®Google Scholar
• Muzykantov VR, Murciano JC, Taylor RP, Atochina EN, Herraez A. Regulation of the complement-mediated elimination of red blood cells modified with biotin and streptavidin. Anal Biochem 1996; 241: 109–19
   PubMed Web of Science ®Google Scholar
• Muzykantov VR, Sakharov DV, Domogatsky SP, Goncharov NV, Danilov SM. Directed targeting of immunoerythrocytes provides local protection of endothelial-cells from damage by hydrogen-peroxide. Am J Pathol 1987; 128: 276–85
   PubMed Web of Science ®Google Scholar
• Muzykantov VR, Sakharov DV, Smirnov MD, Domogatsky SP, Samokhin GP. Targeting of enzyme immobilized on erythrocyte-membrane to collagen-coated surface. FEBS Lett 1985; 182: 62–6
   PubMed Web of Science ®Google Scholar
• Muzykantov VR, Smirnov MD, Klibanov AL. Avidin attachment to red-blood-cells via a phospholipid derivative of biotin provides complement-resistant immunoerythrocytes. J Immunol Methods 1993; 158: 183–90
   PubMed Web of Science ®Google Scholar
• Muzykantov VR, Smirnov MD, Samokhin GP. Avidin attachment to biotinylated erythrocytes induces homologous lysis via the alternative pathway of complement. Blood 1991; 78: 2611–18
   PubMed Web of Science ®Google Scholar
• Muzykantov VR, Smirnov MD, Samokhin GP. Avidin-induced lysis of biotinylated erythrocytes by homologous complement via the alternative pathway depends on avidin's ability of multipoint binding with biotinylated membrane. Biochim Biophys Acta 1992; 1107: 119–25
   PubMed Web of Science ®Google Scholar
• Muzykantov VR, Taylor RP. Attachment of biotinylated antibody to red-blood-cells - antigen-binding capacity of immunoerythrocytes and their susceptibility to lysis by complement. Anal Biochem 1994; 223: 142–8
   PubMed Web of Science ®Google Scholar
• Pierige F, Serafini S, Rossi L, Magnani A. Cell-based drug delivery. Adv Drug Deliv Rev 2008; 60: 286–95
   PubMed Web of Science ®Google Scholar
• Reddy LH. Drug delivery to tumours: Recent strategies. J Pharm Pharmacol 2005; 57: 1231–42
   PubMed Web of Science ®Google Scholar
• Rossi L, Serafini S, Pierige F, Antonelli A, Cerasi A, Fraternale A, Chiarantini L, Magnani M. Erythrocyte-based drug delivery. Expert Opin Drug Deliv 2005; 2: 311–22
   PubMedGoogle Scholar
• Sauer I, Nikolenko H, Keller S, Abu Ajaj K, Bienert M, Dathe M. Dipalmitoylation of a cellular uptake-mediating apolipoprotein e-derived peptide as a promising modification for stable anchorage in liposomal drug carriers. Biochim Biophys Acta 2006; 1758: 552–61
   PubMed Web of Science ®Google Scholar
• Schneider J, Nicolay JP, Foller M, Wieder T, Lang F. Suicidal erythrocyte death following cellular K+ loss. Cell Physiol Biochem 2007; 20: 35–44
   Google Scholar
• Staedtke V, Brahler M, Muller A, Georgieva R, Bauer S, Sternberg N, Voigt A, Lemke A, Keck C, Moschwitzer J, et al. In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cells. Small 2010; 6: 96–103
   PubMed Web of Science ®Google Scholar
• Sternberg N, Müller A, Müller M, Abdallah Z, Georgieva R, Baumler H, 2009. Loaded red blood cells as natural micro carriers for targeted drug delivery, 4th Fabisch Symposium, Charité, Berlin, Germany
   Google Scholar
• Walls R, Kumar KS, Hochstein P. Aging human erythrocytes. Differential sensitivity of young and old erythrocytes to hemolysis induced by peroxide in the presence of thyroxine. Arch Biochem Biophys 1976; 174: 463–8
   Google Scholar
• Wu HC, Chang DK. Peptide-mediated liposomal drug delivery system targeting tumor blood vessels in anticancer therapy. J Oncol 2010; 2010: 723–798
   Google Scholar
• Xiang J, Tang J, Song C, Yang Z, Hirst DG, Zheng QJ, Li G. Mesenchymal stem cells as a gene therapy carrier for treatment of fibrosarcoma. Cytotherapy 2009; 11: 516–26
   PubMed Web of Science ®Google Scholar
• Zaltzman AB, Van den Berg CW, Muzykantov VR, Morgan BP. Enhanced complement susceptibility of avidin-biotin-treated human erythrocytes is a consequence of neutralization of the complement regulators cd59 and decay accelerating factor. Biochem J 1995; 307(Pt 3)651–6
   PubMedGoogle Scholar